Immunotherapy Promising for Slowing Progression of ALS

MONDAY, June 4, 2018 -- A new immunotherapy appears to be well tolerated and possibly of benefit in patients with amyotrophic lateral sclerosis (ALS), according to a phase 1, first-in-human study published online May 18 in Neurology: Neuroimmunology...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news